Cure My Disease

Don't miss your cure!

 Log in / Sign up

A simple care plan may shield older brains after surgery

NCT ID NCT07787832

Prevention Sponsor: Universitätsklinikum Hamburg-Eppendorf Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This study evaluates a multicomponent care program designed to prevent postoperative delirium in adults aged 65 and older undergoing surgery. The program includes preoperative screening for risk factors like frailty and cognitive impairment, patient and family education, and individualized measures such as orientation support, early mobilization, and reducing delirium-inducing medications. Researchers will follow participants from before surgery to three months after, tracking delirium rates, cognitive function, independence, and complications. The goal is to see if better implementation of the program leads to fewer cases of delirium and improved recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A multicomponent behavioral care program including preoperative screening, patient education, and individualized measures to support orientation, hydration, nutrition, mobility, and sleep.
What this could lead to
If effective, this program could reduce postoperative delirium in older adults, potentially leading to shorter hospital stays, better cognitive outcomes, and preserved independence after surgery.
What could go wrong
This is an observational evaluation of a program being rolled out in practice, not a controlled trial, so results may be influenced by other factors. The program's success depends on consistent implementation across different hospital settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 720 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥65 years * Scheduled for or undergoing inpatient surgery at the study site * Able to provide written informed consent * Sufficient language proficiency to understand the study information and complete the study assessments Exclusion Criteria: * Current schizophrenia * Active alcohol dependence or harmful alcohol use * Current drug abuse * severe intellectual disability * Preoperative delirium * Inability to understand the nature, significance, and implications of study participation or to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Delirium prevention are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

delirium Emergence Delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Delirium prevention Multicomponent care program Older adults (60 - 85 years old) Postoperative delirium

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.